This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hereditary Myopathy Due to Absence of Muscle Phosphorylase

LEWIS P. ROWLAND, MD; STANLEY FAHN, MD; DONALD L. SCHOTLAND, MD

Arch Neurol. 1963;9(4):325-342.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The form of glycogen storage disease due to absence of muscle phosphorylase has a remarkable history. McArdle⁴⁸ described the first case in 1951 and postulated that the disorder was due to a defect in glycogen breakdown. There were no further examples until 1959, when two cases were reported almost simultaneously. The enzymatic defect was clearly established in the investigation of these two cases by Pearson, Mommaerts, Rimer, and Illingworth in one^50,58,59 and by Schmid, Mahler, Robbins, Larner, and Villar-Palasi in the other.^40,68-70 This rapid elucidation of a disease is unparalled in medical annals.

Although rare, the disease is important. It is the first of the hereditary myopathies in which the metabolic defect is known. Furthermore, investigations of the manifestations of the disease will provide important information regarding the role of glycogen in normal muscle metabolism. In addition, the existence of this disease has provided information regarding the . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Associate Professor of Neurology, College of Physicians and Surgeons, Columbia University, Co-Director, Neurological Clinical Research Center (Dr. Rowland); formerly Assistant Resident in Neurology, Columbia-Presbyterian Medical Center, currently Research Associate, National Institute of Neurological Diseases and Blindness, National Institutes of Health, Bethesda, Md (Dr. Fahn); Visiting Fellow in Neuropathology, College of Physicians and Surgeons, Columbia University, USPHS Grants BT 815 and 2B-5062 (C7), National Institute of Neurological Diseases and Blindness, National Institutes of Health (Dr. Schotland).

Departments of Neurology and Pathology, College of Physicians and Surgeons, Columbia University, and Neurological Clinical Research Center, Columbia-Presbyterian Medical Center, New York.

Footnotes
Presented at the 88th Annual Meeting of the American Neurological Association, Atlantic City, June 10-12, 1963.15

Aided by USPHS Grants B-3359 and B-1620 (C4).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?